Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Quality of life in women with genitourinary syndrome of menopause, in Quindío, Colombia
PDF (Español (España))

Keywords

Quality of Life
Women
Estrogens
Postmenopause
Atrophic Vaginitis
Health Evaluation
Survival

How to Cite

Espitia de La Hoz, F. J. (2023). Quality of life in women with genitourinary syndrome of menopause, in Quindío, Colombia. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 10(1). https://doi.org/10.53853/encr.10.1.761

Abstract

Background: the genitourinary syndrome of menopause (GSM) is a highly prevalent clinical condition, with significant adverse effects on the quality of life of women who suffer from it.

Purpose: To evaluate the quality of life and the clinical characteristics in women with genitourinary syndrome of menopause GSM.

Methodology: randomized cross-sectional study. 235 women aged 40 years or older, postmenopausal, with a diagnosis of GSM were included. Scores from the Short Form-36 Health Survey (SF-36) quality of life questionnaire and the Menopause Rating Scale (MRS) were measured.

Results: Age showed a median of 51 years. In the SF-36 questionnaire, “General Health” obtained the lowest score, followed by “Physical Function”. In the total population, the most frequent symptoms were vaginal dryness and sexual problems. On the MRS scale, the domain most affected was the urogenital with severe intensity. The global score of the MRS scale is classified in the moderate intensity category, but in the group over 60 years of age, the score is higher, translating into a poorer quality of life, at the expense of the urogenital domain.

Conclusions: women with GSM showed deterioration in the quality of life, presenting more severe urogenital and somatic symptoms after 60 years. Studies on the prognosis of this condition in postmenopausal women are necessary.

https://doi.org/10.53853/encr.10.1.761
PDF (Español (España))

References

Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063-8. https://doi.org/10.1097/GME.0000000000000329

Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704-11. https://doi.org/10.1016/j.ajog.2016.07.045

Espitia De La Hoz FJ. Prevalence of genitourinary syndrome of menopause and impact on sexuality of women in Quindío (Colombia), 2013-2016. Rev Colomb Obstet Ginecol. 2018;69(4):249-5. https://doi.org/10.18597/rcog.3111

Moral E, Delgado JL, Carmona F, Caballero B, Guillán C, González PM, et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018;21(2):167-73. https://doi.org/10.1080/13697137.2017.1421921

Palma F, Volpe A, Villa P, Cagnacci A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2016;83:40-4. https://doi.org/10.1016/j.maturitas.2015.09.001

Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509-22. https://doi.org/10.3109/13697137.2010.522875

Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey. Climacteric. 2012;15(1):36-44. https://doi.org/10.3109/13697137.2011.647840

Kim HK, Kang SY, Chung YJ, Kim JH, Kim MR. The Recent Review of the Genitourinary Syndrome of Menopause. J Menopausal Med. 2015;21(2):65-71. https://doi.org/10.6118/jmm.2015.21.2.65

Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc). 1995;104(20):771-6.

Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes. 2004;2:45. https://doi.org/10.1186/1477-7525-2-45

Lugo LH, García H, Gómez C. Confiabilidad del cuestionario de calidad de vida en salud SF-36 en Medellín, Colombia. Rev Fac Nac Salud Pública. 2006;24(2):37-50.

Monterrosa-Castro A, Paternina-Caicedo AJ, Herazo-Acevedo E, Oviedo-Acevedo HC, Campo-Arias A. Utilidad de menopause rating scale (MRS) en indígenas colombianas en climaterio. Duazary. 2017;14(1):8-15. https://doi.org/10.21676/2389783X.1737

McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247-63. https://doi.org/10.1097/00005650-199303000-00006

Ferrer M, Alonso J. The use of the Short Form (SF)-36 questionnaire for older adults. Age Ageing. 1998;27(6):755-6. https://doi.org/10.1093/ageing/27.6.755

Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83. https://doi.org/10.1097/00005650-199206000-00002

Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HP. Evaluation der klimakterischen Beschwerden (Menopause Rating Scale [MRS]) [Evaluation of climacteric symptoms (Menopause Rating Scale)]. Zentralbl Gynakol. 1994;116(1):16-23.

Metintas S, Arýkan I, Kalyoncu C, Ozalp S. Menopause Rating Scale as a screening tool in rural Turkey. Rural Remote Health. 2010;10(1):1230. https://doi.org/10.22605/RRH1230

Heinemann LA, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HP. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes. 2004;2:67. https://doi.org/10.1186/1477-7525-2-67

Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003;1:28. https://doi.org/10.1186/1477-7525-1-28

World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving hu-man subjects. J Am Med Assoc. 2015;310(20):2013-6. https://doi.org/10.1001/jama.2013.281053

Ministerio de Salud y Protección Social. Resolución 8430 de 1993, por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Constitución Política de Colombia. 1993:1-12. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF

Pinkerton JV, Bushmakin AG, Komm BS, Abraham L. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Maturitas. 2017;100:57-63. https://doi.org/10.1016/j.maturitas.2017.03.315

Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013;10(9):2232-41. https://doi.org/10.1111/jsm.122 35

Nappi RE, Palacios S, Particco M, Panay N. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs. Maturitas. 2016;91:81-90. https://doi.org/10.1016/j.maturitas.2016.06.010

Espitia De La Hoz FJ, Orozco-Gallego H. Estriol vs. estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia. Ginecol obstet Méx. 2018;86(2):117-26. https://doi.org/10.24245/gom.v86i2.1881

Espitia De La Hoz FJ. Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019. Rev Cienc Bioméd. 2021;10(3):152-62. https://doi.org/10.32997/rcb-2021-3497

Briggs P. Genitourinary syndrome of menopause. Post Reprod Health. 2020;26(2):111-4. https://doi.org/10.1177/2053369119884144

Ojha N, Bista KD, Bajracharya S, Katuwal N. Genitourinary Syndrome of Menopause among Postmenopausal Women in a Tertiary Care Centre: A Descriptive Cross-sectional Study. J Nepal Med Assoc. 2022 febr. 15;60(246):126-31. https://doi.org/10.31729/jnma.7237

Espitia De La Hoz FJ. Tratamiento no hormonal del síndrome genitourinario de la menopausia. Arch Med (Manizales). 2021;21(2):509-22. https://doi.org/10.30554/archmed.21.2.3996.2021

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.